Cite
Acceptance of stakeholder comments during EMA scientific guideline public consultations: Legitimacy of the quadruple helix model of innovation.
MLA
Heikkinen, Inkatuuli, and Aimad Torqui. “Acceptance of Stakeholder Comments during EMA Scientific Guideline Public Consultations: Legitimacy of the Quadruple Helix Model of Innovation.” British Journal of Clinical Pharmacology, vol. 89, no. 3, Mar. 2023, pp. 1003–11. EBSCOhost, https://doi.org/10.1111/bcp.15542.
APA
Heikkinen, I., & Torqui, A. (2023). Acceptance of stakeholder comments during EMA scientific guideline public consultations: Legitimacy of the quadruple helix model of innovation. British Journal of Clinical Pharmacology, 89(3), 1003–1011. https://doi.org/10.1111/bcp.15542
Chicago
Heikkinen, Inkatuuli, and Aimad Torqui. 2023. “Acceptance of Stakeholder Comments during EMA Scientific Guideline Public Consultations: Legitimacy of the Quadruple Helix Model of Innovation.” British Journal of Clinical Pharmacology 89 (3): 1003–11. doi:10.1111/bcp.15542.